Monthly Archives: February 2019

Molecular Partners reports key financials for FY 2018 and corporate highlights for Q4 2018

By | Uncategorized | No Comments

Molecular Partners announced its unaudited financial results for 2018 and corporate highlights for the fourth quarter 2018. The fourth quarter was marked by positive phase 3 efficacy data presented for abicipar as well as the initiation of a strategic collaboration with Amgen in the field of immuno-oncology, two key milestones for the company.

Read More